Inhibikase Therapeutics, Inc. (IKT)
$2.50+4.60%Close
BUYBULL · day 30
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $330M
- Avg volume
- 827.1K
- Beta
- 0.95
- P/E (TTM)
- -5.26
- Short % float
- 11.84%
- Days to cover
- 21.5
- SI change
- +4.8%
- 1W
- +4.60%
- 1M
- +7.30%
- 3M
- +47.93%
- YTD
- +28.21%
- vs SPY 1W
- +5.79%
- vs SPY 1M
- +3.98%
- vs SPY 3M
- +45.54%
- vs SPY YTD
- +16.45%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CMMBBUYChemomab Therapeutics Ltd.RECOVERYQ -15$2.17+0.46%
- MAIABUYMAIA Biotechnology, Inc.RECOVERYQ -7$1.35-2.88%
- MSLEBUYSatellos Bioscience Inc. Common StockBEARQ 7$9.47-5.39%
- OKYOSELLOKYO Pharma LimitedRECOVERYQ 0$1.50-2.60%
- PTPIBUYPetros Pharmaceuticals, Inc.RECOVERYQ -27$0.00
- MXCTBUYMaxCyte, Inc.RECOVERYQ 13$1.39+0.72%
- XTNTSELLXtant Medical Holdings, Inc.CRISISQ -7$0.32+0.00%
- ICUSELLSeaStar Medical Holding CorporationRECOVERYQ -28$3.19-4.78%
- AKTSBUYAktis Oncology, Inc.Q 31$25.98+7.94%
- ALGSBUYAligos Therapeutics, Inc.RECOVERYQ -21$6.93+3.90%
- ANEBBUYAnebulo Pharmaceuticals, Inc.CRISISQ -4$0.31-6.06%
- HTFLBUYHeartflow, Inc. Common StockRECOVERYQ 46$50.20+0.90%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
